To evaluate choroidal thickness (CT) in retinitis pigmentosa (RP) using enhanced depth imaging (EDI) optical coherence tomography (OCT).
Methods:
A retrospective analysis of a group of patients with RP who underwent EDI-OCT was performed. Choroidal thickness measurements were compared with those of age- and sex-matched healthy subjects. In the RP group, the possible association between subfoveal CT and some clinical parameters (visual acuity, age, age at disease onset, duration of the disease, macular thickness, visual field loss, electroretinography [ERG]) was evaluated.
Results:
The study recruited 39 patients with RP with an average age of 43.3 ± 11.3 years while the control group consisted of 73 healthy subjects with an average age of 42.9 ± 12.10 years. On average, CT was significantly thinner in the RP group compared to the controls (p<0.0001). In the RP group, we could not find any significant association between CT and the considered clinical parameters even if there was a trend for decreasing CT with increasing age (r = −0.23, p = 0.096). In the control group, subfoveal CT showed a slightly significant correlation with age (r = −0.21, p = 0.04) but not with macular thickness and visual acuity.
Conclusions:
In our series, CT was significantly lower in the RP group in comparison with the controls, as measured by EDI-OCT, but did not correlate with age, age at onset, duration of the disease, macular thickness, visual acuity, visual field loss, or ERG responses. Although the clinical implications of choroidal changes in RP have not yet been clearly determined, the evaluation of choroidal features may provide information that could be useful to clarify the pathophysiology of the disease.
PuechBKostrubiecBHacheJCFrançoisP. [Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France]. J Fr Ophtalmol. 1991;14(3):153-164.
SchmidtKGPillunatLEKohlerKFlammerJ. Ocular pulse amplitude is reduced in patients with advanced retinitis pigmentosa. Br J Ophthalmol. 2001;85(6):678-682.
6.
FalsiniBAnselmiGMMarangoniDet al. Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52(2):1064-1069.
7.
ZhangYHarrisonJMNaterasOSChalfinSDuongTQ. Decreased retinal-choroidal blood flow in retinitis pigmentosa as measured by MRI. Doc Ophthalmol. 2013;126(3):187-197.
8.
MurakamiYIkedaYAkiyamaMet al. Correlation between macular blood flow and central visual sensitivity in retinitis pigmentosa. Acta Ophthalmol. 2015;93(8):e644-e648.
MargolisRSpaideRF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147(5):811-815.
11.
ChhablaniJWongIYKozakI. Choroidal imaging: A review. Saudi J Ophthalmol. 2014;28(2):123-128.
12.
SpaideRF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009;147(4):644-652.
13.
FujiwaraTImamuraYMargolisRSlakterJSSpaideRF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009;148(3):445-450.
14.
ImamuraYFujiwaraTMargolisRSpaideRF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29(10):1469-1473.
15.
YeohJRahmanWChenFet al. Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2010;248(12):1719-1728.
DhootDSHuoSYuanAet al. Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomography. Br J Ophthalmol. 2013;97(1):66-69.
18.
AdhiMRegatieriCVBranchiniLAZhangJYAlwassiaAADukerJS. Analysis of the morphology and vascular layers of the choroid in retinitis pigmentosa using spectral-domain OCT. Ophthalmic Surg Lasers Imaging Retina. 2013;44(3):252-259.
19.
YoonCKYuHGYoonCK. The Structure-Function Relationship between Macular Morphology and Visual Function Analyzed by Optical Coherence Tomography in Retinitis Pigmentosa. J Ophthalmol. 2013;2013:821460.
20.
FinziACelliniMStrobbeECamposEC. ET-1 plasma levels, choroidal thickness and multifocal electroretinogram in retinitis pigmentosa. Life Sci. 2014;118(2):386-390.
21.
StrobbeECelliniMFresinaMCamposEC. ET-1 Plasma Levels, Aqueous Flare, and Choroidal Thickness in Patients with Retinitis Pigmentosa. J Ophthalmol. 2015;2015:292615.
22.
MarmorMFHolderGESeeligerMWYamamotoS. International Society for Clinical Electrophysiology of Vision. Standard for clinical electroretinography (2004 update). Doc Ophthalmol. 2004;108(2):107-114.
23.
TanCSOuyangYRuizHSaddaSR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(1):261-266.
24.
ManjunathVTahaMFujimotoJGDukerJS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010;150(3):325-329. e1.
25.
BranchiniLRegatieriCVFlores-MorenoIBaumannBFujimotoJGDukerJS. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology. 2012;119(1):119-123.
26.
ChhablaniJBarteselliGWangHet al. Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(4):2274-2280.
27.
YamashitaTYamashitaTShirasawaMArimuraNTerasakiHSakamotoT. Repeatability and reproducibility of subfoveal choroidal thickness in normal eyes of Japanese using different SD-OCT devices. Invest Ophthalmol Vis Sci. 2012;53(3):1102-1107.
28.
LeeSFallahNForooghianFet al. Comparative analysis of repeatability of manual and automated choroidal thickness measurements in nonneovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54(4):2864-2871.
29.
ShaoLXuLChenCXet al. Reproducibility of subfoveal choroidal thickness measurements with enhanced depth imaging by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(1):230-233.
30.
MilamAHLiZYFarissRN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17(2):175-205.
31.
YuDYCringleSJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res. 2005;80(6):745-751.
32.
ViringipurampeerIABasharAEGregory-EvansCYMoritzOLGregory-EvansK. Targeting inflammation in emerging therapies for genetic retinal disease. Int J Inflam. 2013;2013:581751.
33.
YoshidaNIkedaYNotomiSet al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):e5-e12.
34.
Martínez-Fernández de la CámaraCSalomDSequedoMDet al. Altered antioxidant-oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. PLoS One. 2013;8(9):e74223.
35.
SorrentinoFSBonifazziCPerriP. The Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis Pigmentosa. J Ophthalmol. 2015;2015:405234.
36.
MarnerosAGFanJYokoyamaYet al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol. 2005;167(5):1451-1459.
37.
Saint-GeniezMMaldonadoAEDAmorePA. VEGF expression and receptor activation in the choroid during development and in the adult. Invest Ophthalmol Vis Sci. 2006;47(7):3135-3142.
38.
Saint-GeniezMKuriharaTSekiyamaEMaldonadoAEDAmorePA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A. 2009;106(44):18751-18756.
39.
IkunoYKawaguchiKNouchiTYasunoY. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2010;51(4):2173-2176.
